Luminescent Rhenium(I) Phenanthroline Complexes with a Benzoxazol-2-ylidene Ligand: Synthesis, Characterization, and Photophysical Study

Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives

Organometallic compounds are increasingly recognized as promising anticancer and antibiotic drug candidates. Among the transition metal ions investigated for these purposes, rhenium occupies a special role. Its tri- and dicarbonyl complexes, in particular, attract continuous attention due to their relative ease of preparation, stability and unique photophysical and luminescent properties that allow the combination of diagnostic and therapeutic purposes, thereby permitting, e.g., molecules to be tracked within cells. In this review, we discuss the anticancer and antibiotic properties of rhenium tri- and dicarbonyl complexes described in the last seven years, mainly in terms of their structural variations and in vitro efficacy. Given the abundant literature available, the focus is initially directed on tricarbonyl complexes of rhenium. Dicarbonyl species of the metal ion, which are slowly gaining momentum, are discussed in the second part in terms of future perspective for the possible developments in the field.

Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics

Globally, cancer is the second (to cardiovascular diseases) leading cause of death. Regardless of various efforts (i.e., finance, research, and workforce) to advance novel cancer theranostics (diagnosis and therapy), there have been few successful attempts towards ongoing clinical treatment options as a result of the complications posed by cancerous tumors. In recent years, the application of magnetic nanomedicine as theranostic devices has garnered enormous attention in cancer treatment research. Magnetic nanoparticles (MNPs) are capable of tuning the magnetic field in their environment, which positively impacts theranostic applications in nanomedicine significantly. MNPs are utilized as contrasting agents for cancer diagnosis, molecular imaging, hyperfusion region visualization, and T cell-based radiotherapy because of their interesting features of small size, high reactive surface area, target ability to cells, and functionalization capability. Radiolabelling of NPs is a powerful diagnostic approach in nuclear medicine imaging and therapy. The use of luminescent radioactive rhenium(I), 188/186Re, tricarbonyl complexes functionalised with magnetite Fe3O4 NPs in nanomedicine has improved the diagnosis and therapy of cancer tumors. This is because the combination of Re(I) with MNPs can improve low distribution and cell penetration into deeper tissues.

Targeted Synthesis of NIR Luminescent Rhenium Diimine cis,trans-[Re( N N )(CO)2 (L)2 ]n+ Complexes Containing N-Donor Axial Ligands: Photophysical, Electrochemical, and Theoretical Studies

The combined action of ultraviolet irradiation and microwave heating onto acetonitrile solution of [Re( N N )(CO)₃ (NCMe)]OTf ( N N =phenantroline and neocuproine) afforded cis,trans-Re( N N )(CO)₂ (NCMe)₂ ]⁺ acetonitrile derivatives. Substitution of relatively labile NCMe with a series of aromatic N-donor ligands (pyridine, pyrazine, 4,4'-bipyridine, N-methyl-4,4'-bipyridine) gave a novel family of the diimine cis,trans-[Re( N N )(CO)₂ (L)₂ ]⁺ complexes. Photophysical studies of the obtained compounds in solution revealed unusually high absorption across the visible region and NIR phosphorescence with emission band maxima ranging from 711 to 805 nm. The nature of emissive excited states was studied using DFT calculations to show dominant contribution of ³ MLCT (dπ(Re)→π*( N N )) character. Electrochemical (CV and DPV) studies of the monocationic diimine complexes revealed one reduction and one oxidation wave assigned to reduction of the diimine moiety and oxidation of the rhenium center, respectively.

Luminescent Rhenium(I)tricarbonyl Complexes Containing Different Pyrazoles and Their Successive Deprotonation Products: CO2 Reduction Electrocatalysts

Cationic fac-[Re(CO)₃(pz*H)(pypzH)]OTf (pz*H = pyrazole, pzH; 3,5-dimethylpyrazole, dmpzH; indazole, indzH; 3-(2-pyridyl)pyrazole, pypzH) were obtained from fac-[ReBr(CO)₃(pypzH)] by halide abstraction with AgOTf and subsequent addition of the corresponding pyrazole. Successive deprotonation with Na₂CO₃ and NaOH gave neutral fac-[Re(CO)₃(pz*H)(pypz)] and anionic Na{fac-[Re(CO)₃(pz*)(pypz)]} complexes, respectively. Cationic fac-[Re(CO)₃(pz*H)(pypzH)]OTf, neutral complexes fac-[Re(CO)₃(pz*H)(pypz)], and fac-[Re(CO)₃(pypz)₂Na] were subjected to photophysical and electrochemical studies. They exhibit phosphorescent decays from a prevalently ³MLCT excited state with quantum yields (Φ) in the range between 0.03 and 0.58 and long lifetimes (τ from 220 to 869 ns). The electrochemical behavior in Ar atmosphere of cationic and neutral complexes indicates that the oxidation processes assigned to Re^I → Re^II occurs at lower potentials for the neutral complex compared to cationic complex. The reduction processes occur at the ligands and do not depend on the charge of the complexes. The electrochemical behavior in CO₂ saturated media is consistent with CO₂ electrocatalyzed reduction, where the values of the catalytic activity [i_cat(CO₂)/i_cat(Ar)] ranged from 2.7 to 11.5 (compared to 8.1 for fac-[Re(CO)₃Cl(bipy)] studied as a reference). Controlled potential electrolysis for the pyrazole cationic (3a) and neutral (4a) complexes after 1 h affords CO in faraday yields of 61 and 89%, respectively. These values are higher for indazole complexes and may be related to the acidity of the coordinated pyrazole.

Exploring the In Vivo and In Vitro Anticancer Activity of Rhenium Isonitrile Complexes

The established platinum-based drugs form covalent DNA adducts to elicit their cytotoxic response. Although they are widely employed, these agents cause toxic side-effects and are susceptible to cancer-resistance mechanisms. To overcome these limitations, alternative metal complexes containing the rhenium(I) tricarbonyl core have been explored as anticancer agents. Based on a previous study ( Chem. Eur. J. 2019, 25, 9206), a series of highly active tricarbonyl rhenium isonitrile polypyridyl (TRIP) complexes of the general formula fac-[Re(CO)3(NN)(ICN)]+, where NN is a chelating diimine and ICN is an isonitrile ligand, that induce endoplasmic reticulum (ER) stress via activation of the unfolded protein response (UPR) pathway are investigated. A total of 11 of these TRIP complexes were synthesized, modifying both the equatorial polypyridyl and axial isonitrile ligands. Complexes with more electron-donating equatorial ligands were found to have greater anticancer activity, whereas the axial ICN ligands had a smaller effect on their overall potency. All 11 TRIP derivatives trigger a similar phenotype that is characterized by their abilities to induce ER stress and activate the UPR. Lastly, we explored the in vivo efficacy of one of the most potent complexes, fac-[Re(CO)3(dmphen)(ptolICN)]+ (TRIP-1a), where dmphen = 2,9-dimethyl-1,10-phenanthroline and ptolICN = para-tolyl isonitrile, in mice. The 99mTc congener of TRIP-1a was synthesized, and its biodistribution in BALB/c mice was investigated in comparison to the parent Re complex. The results illustrate that both complexes have similar biodistribution patterns, suggesting that 99mTc analogues of these TRIP complexes can be used as diagnostic partner agents. The in vivo antitumor activity of TRIP-1a was then investigated in NSG mice bearing A2780 ovarian cancer xenografts. When administered at a dose of 20 mg/kg twice weekly, this complex was able to inhibit tumor growth and prolong mouse survival by 150% compared to the vehicle control cohort.

Towards better understanding of photophysical properties of rhenium(I) tricarbonyl complexes with terpy-like ligands

Series of Re(I) carbonyls complexes were designed and synthesized to explore the impact of the triimine skeleton and number of methoxy groups attached to aryl substituents on their optoelectronic and thermal properties. The chemical structures of the prepared complexes were confirmed by ¹H and ¹³C NMR spectroscopy, HR-MS, elemental anlsysis, and X-ray measurements. DSC measuremtns showed that they melted in the range of 198-325 °C. Some of them form stable molecular glasses with high glass transition temperatures (158-173 °C). Experimentally obtained optical properties were supported by DFT calculations. The UV-Vis spectra display a series of overlapping absorption bands in the range 200-350 nm, and much weaker broad band in the visible spectral region, due to intraligand and charge transfer transitions, respectively. All synthesized complexes were emissive in solution and in solid state as powder. Moreover, when applied in diodes, some of them exhibited ability for emission of light under external voltage with maximum of electroluminescence band located at 591-630 nm.

Mechanochemical changes on cyclometalated Ir(iii) acyclic carbene complexes – design and tuning of luminescent mechanochromic transition metal complexes

A new class of luminescent cyclometalated Ir(iii) complexes with readily tunable mechanochromic properties derived from the mechanically induced trans-to-cis isomerization have been developed.

Electronic Communication in Luminescent Dicyanorhenate-Bridged Homotrinuclear Rhenium(I) Complexes

A series of cyano-bridged homotrinuclear Re(I) complexes with the general formula of {[Re]'[Re][Re]'}⁺ {[Re]' = -[Re^I(CO)₂(LL)(X)]; [Re] = -[(NC)Re^I(CO)₂(phen)(CN)]-; LL = diimine, diphosphine, or two carbonyl ligands; X = triphenylphosphine or carbonyl ligand} and the corresponding mononuclear complex analogues were synthesized. The structures of most of the trinuclear Re(I) complexes have been determined by X-ray crystallography. The relative orientations of peripheral to central Re(I) units in these structures vary considerably. The photophysical properties of these trinuclear Re(I) complexes have been examined. Except for the trinuclear Re(I) complex with Br₂phen ligand, all the other triads display orange to red photoluminescence derived from the ³MLCT [dπ(Re) → π*(phen)] origin of the central Re(I) unit, suggestive of efficient energy transfer between the peripheral chromophores and the central unit. In addition to the efficient energy transfer processes between the Re(I) chromophores in these trinuclear complexes, the ability of the [NC-Re-CN] bridging ligands for electronic coupling between the rhenium metal centers is evidenced by ca. 0.2-0.3 V separation of the two rhenium metal-based oxidation potentials of the chemically equivalent peripheral units.

Supramolecular Construction of Cyanide-Bridged ReI Diimine Multichromophores

The reactions of labile [Re(diimine)(CO)₃(H₂O)]⁺ precursors (diimine = 2,2'-bipyridine, bpy; 1,10-phenanthroline, phen) with dicyanoargentate anion produce the dirhenium cyanide-bridged compounds [{Re(diimine)(CO)₃}₂CN)]⁺ (1 and 2). Substitution of the axial carbonyl ligands in 2 for triphenylphosphine gives the derivative [{Re(phen)(CO)₂(PPh₃)}₂CN]⁺ (3), while the employment of a neutral metalloligand [Au(PPh₃)(CN)] affords heterobimetallic complex [{Re(phen)(CO)₃}NCAu(PPh₃)]⁺ (4). Furthermore, the utilization of [Au(CN)₂]^-, [Pt(CN)₄]^2-, and [Fe(CN)₆]^4-/3- cyanometallates leads to the higher nuclearity aggregates [{Re(diimine)(CO)₃NC} _xM] ^m+ (M = Au, x = 2, 5 and 6; Pt, x = 4, 7 and 8; Fe, x = 6, 9 and 10). All novel compounds were characterized crystallographically. Assemblies 1-8 are phosphorescent both in solution and in the solid state; according to the DFT analysis, the optical properties are mainly associated with charge transfer from Re tricarbonyl motif to the diimine fragment. The energy of this process can be substantially modified by the properties of the ancillary ligands that allows to attain near-IR emission for 3 (λ_em = 737 nm in CH₂Cl₂). The Re-Fe^II/III complexes 9 and 10 are not luminescent but exhibit low energy absorptions, reaching 846 nm (10) due to Re^I → Fe^III transition.

Synthesis of Re(I) Rings Comprising Different Re(I) Units and Their Light-Harvesting Abilities

Trimethylamine N-oxide (Me₃NO) could selectively remove only one CO ligand from fac-[Re(N^N)(CO)₃(PR₂R')]⁺ (N^N = diimine ligand), whereby only the CO ligand in the trans position to the phosphorus ligand was selectively removed to give cis,trans-[Re^I(N^N)(CO)₂(PR₂R')(L)] ⁿ⁺ in good yields. This decarbonylation reaction using Me₃NO was found to be especially useful for synthesizing biscarbonyl Re(I) complexes with electron-withdrawing groups in the diimine ligand, which could not be synthesized or were obtained only in low yields by the photochemical method. Me₃NO also selectively removed the carbonyl ligands in the trans position to the phosphorus ligands from the edge Re(I) complex units, which have the fac-[Re(N^N)(CO)₃(PR₂R')]⁺ structure, in linear-shaped Re(I) multinuclear complexes. This reaction was successfully applied to synthesize a novel precursor with ring-shaped multinuclear Re complexes (Re-rings) comprising different kinds of Re(I) units. The newly synthesized Re-rings, which consist of one Re unit with a 4,4'-bis(trifluoromethyl)-2,2'-bipyridine (CF₃bpy) ligand and one or two Re unit(s) with a 2,2'-bipyridine (bpy) ligand, showed almost quantitative excitation-energy harvesting ability from the Re unit(s) with bpy to that with CF₃bpy.

Benzannulated Re(i)–NHC complexes: synthesis, photophysical properties and antimicrobial activity

A series of novel Re(i)(CO)₃–NHC complexes bearing unsubstituted benzimidazol-2-ylidene ligands is presented which provide strong luminescence as well as high antibacterial activity.

Asymmetric rhenium tricarbonyl complexes show superior luminescence properties in live cell imaging

The synthesis and photophysical properties of a novel series of rhenium tricarbonyl complexes based on tridentate phenanthridinyl-containing ligands are described. Photophysical data reveal beneficial luminescence behaviour especially for compounds with an asymmetric ligand set. These advantageous properties are not limited to organic solvents, but indeed also improved in aqueous solutions. The suitability of our new rhenium complexes as potent imaging agents has been confirmed by fluorescence microscopy on living cancer cells, which also confirms superior long-time stability under fluorescence microscopy conditions. Colocalisation studies with commercial organelle stains reveal an accumulation of the complexes in the endoplasmic reticulum for all tested cell lines.

Photochemical and electrochemical catalytic reduction of CO2 with NHC-containing dicarbonyl rhenium(i) bipyridine complexes

The electrochemical and photochemical catalytic reductions of CO2 using N,O and N,S-NHC-containing dicarbonyl rhenium(i) bipyridine complexes have been investigated. By replacing the carbonyl ligand in tricarbonyl rhenium(i) complexes with a weaker π-accepting ligand, the characteristic MLCT transitions shifted to lower energy. This makes photocatalysts capable of harvesting low-energy visible light for catalyzing CO2 reduction. A detailed study revealed that these dicarbonyl rhenium(i) complexes are also highly selective for photocatalysis of CO2 to CO with a good quantum efficiency (10%), similar to that of the tricarbonyl rhenium(i) complex analogues. From the electrochemical study, it was observed that the catalysts efficiently produce CO from CO2 with high turnover frequency and good stability over time.

Cationic rhenium complexes ligated with N-heterocyclic carbenes – an overview

This review provides an overview of the currently known cationic rhenium NHC complexes.

Potential theranostic and multimodal iron oxide nanoparticles decorated with rhenium-bipyridine and -phenanthroline complexes

Two structurally similar nanoparticles were designed for multimodal imaging and possible radiotherapy. The assembly consists of ultrasmall superparamagnetic iron oxide nanoparticles that act as contrast agents for MRI with a luminescent rhenium complex, for optical imaging, attached to the surface. Rhenium has the advantage of being luminescent and carries two radio-isotopes ¹⁸⁶Re and ¹⁸⁸Re making it possible to act as a contrast agent for SPECT (γ) and to be used for radiotherapy (β). The iron oxide nanoparticles were treated with a silane and further functionalized with picolyl. This picolyl was used to capture rhenium(i)(CO)₃-1,10-phenanthroline (ReL₁) or rhenium(i)(CO)₃-2,2'-bipyridine (ReL₂) and forms the final product Fe₃O₄-picolyl-rhenium(i)(CO)₃-1,10-phenanthroline (IO-ReL₁) or Fe₃O₄-silica-picolyl-rhenium(i)(CO)₃-2,2'-bipyridine (IO-ReL₂), respectively. All products were characterized properly (TEM, XRD, NMR, IR and TXRF) and a full investigation of the relaxometric and optical properties was conducted. Although iron oxide nanoparticles suffer from strong Rayleigh scattering, an efficient sensitized luminescence was observed and the orange emission wavelength was found to be 585 nm for IO-ReL₁ and 592 nm for IO-ReL₂ after irradiation at 395 nm. The relaxometric study of these ultrasmall nanoparticles showed very promising results. The r₂ values measured at a magnetic field strength of 60 MHz of the nanoparticles being 92.9 mM^-1 s^-1 and 97.5 mM^-1 s^-1 for IO-ReL₁ and IO-ReL₂, respectively, were at least 1.5 times larger than Sinerem®.

Palladium(0) NHC complexes: a new avenue to highly efficient phosphorescence

We report the first examples of highly luminescent di-coordinated Pd(0) complexes. Five complexes of the form [Pd(L)(L')] were synthesized, where L = IPr, SIPr or IPr* NHC ligands and L' = PCy₃, or IPr and SIPr NHC ligands. The photophysical properties of these complexes were determined in degassed toluene solution and in the solid state and contrasted to the poorly luminescent reference complex [Pd(IPr)(PPh₃)]. Organic light-emitting diodes were successfully fabricated but attained external quantum efficiencies of between 0.3 and 0.7%.